131 related articles for article (PubMed ID: 22779794)
1. Design, synthesis and antihistamine evaluations of several N-hydroxyalkyl desloratadine analogues.
Lin Y; Wang Y; Sima LF; Wang DH; Chen LG; Li L
Med Chem; 2012 Nov; 8(6):1126-32. PubMed ID: 22779794
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antihistamine evaluations of novel loratadine analogues.
Wang Y; Wang J; Lin Y; Si-Ma LF; Wang DH; Chen LG; Liu DK
Bioorg Med Chem Lett; 2011 Aug; 21(15):4454-6. PubMed ID: 21733682
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological activity evaluation of desloratadine analogues as H1 receptor antagonists.
Lin Y; Wang Y; Sima LF; Wang DH; Cao XH; Chen LG; Chen B
Bioorg Med Chem; 2013 Jul; 21(14):4178-85. PubMed ID: 23719280
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective synthesis of desloratadine derivatives as antagonist of histamine.
Liu GZ; Xu HW; Chen GW; Wang P; Wang YN; Liu HM; Yu DQ
Bioorg Med Chem; 2010 Feb; 18(4):1626-32. PubMed ID: 20110173
[TBL] [Abstract][Full Text] [Related]
5. Anticholinergic effects of desloratadine, the major metabolite of loratadine, in rabbit and guinea-pig iris smooth muscle.
Cardelús I; Antón F; Beleta J; Palacios JM
Eur J Pharmacol; 1999 Jun; 374(2):249-54. PubMed ID: 10422766
[TBL] [Abstract][Full Text] [Related]
6. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects.
Kreutner W; Hey JA; Anthes J; Barnett A; Young S; Tozzi S
Arzneimittelforschung; 2000 Apr; 50(4):345-52. PubMed ID: 10800633
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric Catalysis upon Helically Chiral Loratadine Analogues Unveils Enantiomer-Dependent Antihistamine Activity.
Stone EA; Cutrona KJ; Miller SJ
J Am Chem Soc; 2020 Jul; 142(29):12690-12698. PubMed ID: 32579347
[TBL] [Abstract][Full Text] [Related]
8. N-substituted 11-(4-piperidylene)-5,6-dihydro-11H-benzo-[5,6]cyclohepta [1,2-b]pyridines. Antihistamines with no sedating liability.
Villani FJ; Magatti CV; Vashi DB; Wong J; Popper TL
Arzneimittelforschung; 1986 Sep; 36(9):1311-4. PubMed ID: 2947582
[TBL] [Abstract][Full Text] [Related]
9. Anti-allergic and anti-inflammatory properties of a potent histamine H1 receptor antagonist, desloratadine citrate disodium injection, and its anti-inflammatory mechanism on EA.hy926 endothelial cells.
Jie Q; Kodithuwakku ND; Yuan X; He G; Chen M; Xu S; Wu Y
Eur J Pharmacol; 2015 May; 754():1-10. PubMed ID: 25704613
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of bilastine, desloratadine and rupatadine in the suppression of wheal and flare response induced by intradermal histamine in healthy volunteers.
Antonijoan R; Coimbra J; García-Gea C; Puntes M; Gich I; Campo C; Valiente R; Labeaga L
Curr Med Res Opin; 2017 Jan; 33(1):129-136. PubMed ID: 27659218
[TBL] [Abstract][Full Text] [Related]
11. Desloratadine inhibits constitutive and histamine-stimulated nuclear factor-kappaB activity consistent with inverse agonism at the histamine H1 Receptor.
Wu RL; Anthes JC; Kreutner W; Harris AG; West RE
Int Arch Allergy Immunol; 2004 Dec; 135(4):313-8. PubMed ID: 15564772
[TBL] [Abstract][Full Text] [Related]
12. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 2nd communication: lack of central nervous system and cardiovascular effects.
Kreutner W; Hey JA; Chiu P; Barnett A
Arzneimittelforschung; 2000 May; 50(5):441-8. PubMed ID: 10858871
[TBL] [Abstract][Full Text] [Related]
13. Novel histamine H(3)-receptor antagonists with carbonyl-substituted 4-(3-(phenoxy)propyl)-1H-imidazole structures like ciproxifan and related compounds.
Stark H; Sadek B; Krause M; Hüls A; Ligneau X; Ganellin CR; Arrang JM; Schwartz JC; Schunack W
J Med Chem; 2000 Oct; 43(21):3987-94. PubMed ID: 11052804
[TBL] [Abstract][Full Text] [Related]
14. Studies on heterocyclic compounds: 1,3-thiazolidin-4-one derivatives. V. Pharmacological activity of substituted 2-phenyl-3-(N,N-dimethylaminoprophyl)-1,3-thiazolidin-4-one .
Diurno MV; Piscopo E; Mazzoni O; Calignano A
Boll Soc Ital Biol Sper; 1991 Dec; 67(12):1067-72. PubMed ID: 1840799
[TBL] [Abstract][Full Text] [Related]
15. [(3-Pyridylalkyl)piperidylidene]benzocycloheptapyridine derivatives as dual antagonists of PAF and histamine.
Carceller E; Merlos M; Giral M; Balsa D; Almansa C; Bartrolí J; García-Rafanell J; Forn J
J Med Chem; 1994 Aug; 37(17):2697-703. PubMed ID: 7914928
[TBL] [Abstract][Full Text] [Related]
16. Verapamil, but not probenecid, co-administration can convert desloratadine to a sedating antihistamine in mice.
Katta A; Dhananjeyan M; Bykowski C; Erhardt P; Hacker M; White DB; Bachmann K
Drug Metab Lett; 2007 Jan; 1(1):7-11. PubMed ID: 19356011
[TBL] [Abstract][Full Text] [Related]
17. Non-imidazole histamine H3 ligands, Part 2: New 2-substituted benzothiazoles as histamine H3 antagonists.
Walczyński K; Guryn R; Zuiderveld OP; Timmerman H
Arch Pharm (Weinheim); 1999 Nov; 332(11):389-98. PubMed ID: 10605380
[TBL] [Abstract][Full Text] [Related]
18. 4-[(1H-imidazol-4-yl) methyl] benzamidines and benzylamidines: novel antagonists of the histamine H3 receptor.
Aslanian R; Brown JE; Shih NY; wa Mutahi M; Green MJ; She S; Del Prado M; West R; Hey J
Bioorg Med Chem Lett; 1998 Aug; 8(16):2263-8. PubMed ID: 9873525
[TBL] [Abstract][Full Text] [Related]
19. Antihistamine from Tragia involucrata L. leaves.
Alagar Yadav S; Ramalingam S; Jabamalai Raj A; Subban R
J Complement Integr Med; 2015 Sep; 12(3):217-26. PubMed ID: 26043438
[TBL] [Abstract][Full Text] [Related]
20. Non-imidazole histamine H3 ligands. Part III. New 4-n-propylpiperazines as non-imidazole histamine H3-antagonists.
Walczyński K; Zuiderveld OP; Timmerman H
Eur J Med Chem; 2005 Jan; 40(1):15-23. PubMed ID: 15642406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
